Literature DB >> 162850

Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus.

M M Black, R E Zachrau, B Shore, D H Moore, H P Leis.   

Abstract

A leukocyte migration procedure was utilized to test cellular hypersensitivity of breast cancer patients' leukocytes to autologous and homologous breast cancer tissues and to murine milk containing murine mammary tumor virus (MuMTV). The in vitro responsiveness of the leukocytes and the antigenicity of breast cancer tissues were compared with in vivo prognostically favorable lymphoreticuloendothelial (L-RE) responses seen microscopically at the time of mastectomy and with the results of skin window tests of cellular hypersensitivity. The data suggest that immunogens appear in the in situ phase of the disease and provoke prognostically favorable L-RE responses. These immunogens possess antigenic similarity to some component(s) of MuMTV. Progression of the disease is associated with or preceded by a loss of tissue immunogenicity and/or diminished specific cellular hypersensitivity. The findings are pertinent to investigations of human mammary carcinogenesis and immunoprophylaxis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 162850     DOI: 10.1002/1097-0142(197501)35:1<121::aid-cncr2820350117>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids.

Authors:  S S Witkin; N H Sarkar; D W Kinne; C N Breed; R A Good; N K Day
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

2.  [Cell mediated immunity in cervical cancer patients: evaluation by in vitro leukocyte-migration-inhibition-assay (author's transl)].

Authors:  U D Koenig
Journal:  Arch Gynecol       Date:  1978-12-29

3.  Virolysis of mouse mammary tumor virus by sera from breast cancer patients.

Authors:  S S Witkin; R A Egeli; N H Sarkar; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

4.  Antibodies reactive with murine mammary tumor virus in sera of patients with breast cancer: geographic and family studies.

Authors:  N K Day; S S Witkin; N H Sarkar; D Kinne; D J Jussawalla; A Levin; C C Hsia; N Geller; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

5.  Detection of MMTV-Like sequences in Moroccan breast cancer cases.

Authors:  Meriem Slaoui; Mohammed El Mzibri; Rachid Razine; Zineb Qmichou; Mohammed Attaleb; Mariam Amrani
Journal:  Infect Agent Cancer       Date:  2014-11-10       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.